Bayesian Capital Management, LP Ocular Therapeutix, Inc Call Options Transaction History
Bayesian Capital Management, LP
- $838 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OCUL
# of Institutions
171Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$122 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$108 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$108 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$97.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$71.3 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $654M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...